a multi-histology basket trial of ado-trastuzumab emtansine in patients with her2 amplified cancers
Published 6 years ago • 172 plays • Length 4:35Download video MP4
Download video MP3
Similar videos
-
6:59
ado-trastuzumab emtansine in patients with her2 mutant lung cancers
-
6:01
ado-trastuzumab emansine in patients with her2 amplified salivary gland cancers: results from a ...
-
5:46
adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for her2-positive breast cancer
-
7:45
trastuzumab emtansine in her2 breast cancer
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
6:37
improved idfs for breast cancer patients who received trastuzumab emtansine
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
3:32
enhertu: breakthrough hope for her2 positive cancers
-
21:16
كل ما تريد معرفته عن العلاج الموجه her2 لمرضى سرطان الثدى واثاره الجانبيه وكيفيه التغلب عليها ❤👌
-
4:52
emilia trial: t-dm1 in metastatic breast cancer
-
9:13
substituting trastuzumab emtansine for adjuvant trastuzumab improved idfs for breast cancer pati...
-
5:24
t-dm1 improves overall survival in previously treated advanced cancer patients
-
3:51
study comparing margetuximab combinations to trastuzumab combinations in her2-positive breast cancer
-
1:36
phase 3 trial investigates t-dm1 and pertuzumab in her2 breast cancer
-
10:05
piii trial supports current standard 12-month adjuvant trastuzumab for her2-positive breast cancer
-
7:40
adjuvant trastuzumab did not improve outcomes for patients with her2-low breast cancer
-
4:44
an overview of recent metastatic her2 breast cancer trials
-
0:46
clinical trials remain underway for trastuzumab deruxtecan in her2-positive breast cancer
-
1:31
dr. geyer on the rationale for the katherine trial in her2-positive breast cancer
-
1:09
dr. tripathy on trastuzumab deruxtecan versus t-dm1 in her2-expressing breast cancers
-
5:45
#esmo21 expert video report on targeting in her2-positive metastatic breast and lung cancers
-
0:59
dr o'brien on breast cancer research in patients with her2 brain metastases